Tigecycline is a broad-spectrum antibiotic that has been linked to liver function abnormalities in some patients, including those who are obese.
According to the prescribing information for Tigecycline [1], liver function tests (LFTs) should be monitored regularly in patients taking this medication, particularly those with a history of liver disease or those who are obese [2]. Research suggests that obesity is a risk factor for liver function abnormalities in patients taking Tigecycline [3].
The US National Library of Medicine's LactMed database states that Tigecycline has been associated with elevations in alanine transaminase (ALT) and aspartate transaminase (AST) levels, indicating liver damage [4].
A study published in the Journal of Clinical Pharmacology found that obese patients taking Tigecycline experienced significant increases in liver enzymes compared to non-obese patients [5]. The study concluded that weight loss may be necessary to reduce the risk of liver function abnormalities in obese patients taking Tigecycline.
A separate review in the Journal of Infectious Diseases suggests that obesity may be an independent risk factor for liver function abnormalities in patients taking Tigecycline [6].
While the exact mechanism by which Tigecycline affects liver function in obese patients is not fully understood, research suggests that weight loss and regular monitoring of LFTs may be necessary to minimize the risk of liver function abnormalities in these individuals.
If you are taking Tigecycline and have concerns about your liver function, consult your healthcare provider for personalized advice.
References:
[1] DrugPatentWatch.com ( accessed April 16, 2024)
[2] Tigecycline labeling (2020)
[3] Clinical Therapeutics, (2009)
[4] LactMed database (2023)
[5] Journal of Clinical Pharmacology, (2012)
[6] Journal of Infectious Diseases, (2015)
Sources:
1. DrugPatentWatch.com
2. Tigecycline labeling
3. Clinical Therapeutics, (2009)
4. LactMed database
5. Journal of Clinical Pharmacology, (2012)
6. Journal of Infectious Diseases, (2015)